The difficulties encountered are often extreme, and it is still a very special accomplishment. indeed, to svnthesize such products. This statement is even more applicable to the industrial preparation of polypeptides which might not have been achieved, were it Inot for the extremely high potency of such coinpounds as oxytocini, vasopressiin, and angiotensin, allowing the administration of only small doses and. accordingly, requiring the production of relatively small batches.
The closely related nonapeptides, oxytocin and vasopressin, were the first peptide hormones ever to be synthesized. This pioneering achievement in the years 1953 to 1956 was the work of the school of du Vigneaud.1 In 1956 cainie the first synthesis of a polypeptide antibiotie, gramicidin S, which was, at the same time, the first synthesis of a natural cyclic polypeptide and required special, new methods of preparation. 2 Syntheses of decaand octapeptides of the angiotensin series followed in 1956 to 1958. They were accomplished almost simultaneously bv Page and coworkers3 and by the author's group.4 At t-he same time, a number of analogs with different structures were prepared, about 2 dozen alone by the latter group. [5] [6] [7] More recent syntheses are those of a-MSH and derivatives,8' 9active derivatives of ,8-MSII,10 bradykinin,"1 and, most recently, -active corticotropin peptides. [12] [13] [14] [15] In the field of angiotensin, the octapeptide, isoleucyl-5-angiotensin II, peculiar to equine and porcine species, was synthesized by Page and coworkers3' 7 and also by the author's group. 7 neous efforts of Page in this field, we concentrated mainly on bovine angiotensin, synthesizing the decapeptide, valyl-5-angiotensin I, and the octapeptide, valyl-5-angiotensin IIT.
as well as the corresponding aspartyl-galnides.4',7, 17 The aspartyl-B-anmides of isoleucyl-5-angiotensin II had been prepared earlier.7 18 Skeggs and his colleagues19 synthesized a tetradecapeptide renin substrate which they isolated from tryptic digests of angiotensinogen. Table 1 shows the abbreviated formulae of the angiotensin peptides mentioned here.
Outline of Chemical Synthesis of Valyl-5-Angiotensin II and Its Aspartyl-fl-Amides4-7
All synltheses of angiotensin peptides start fromn I-aminio acids andc use common methods for protectioni of functional groups and for condensations between a-earboxyland a-amino groups. The use of the amide group for the protection of the P-carboxyl-of Asp-1 and its subsequent removal might be called a new feature of polypeptide synthesis introduced during our work on angiotensin.4 7 1 On the whole, a synthesis of angiotensin does not present nearly so severe difficulties as a synthesis of, for example, the eyelic peptide gramicidin S or a tetraeosapeptide with 24 amino acids contained in corticotropin.1 '5 An example of such a synthesis is given in figure 1 . First, amino acid Units are condensed to dipeptide units which, in turn, are condensed together (mostly using dievclohexyl carbodiimide2l) proceedingo from the carboxyl terminal to the N-terminal. One diffieulty may be pointed out: The chemical behavior of the dipeptide Val-Tyr differs to quite an extent from the usual behavior of dipeptides.22 The condensation of this unit to the C-terminal tetrapeptide unit with dicyclohexyl carbodiimide proceeded with some configurational change at the tyrosine. Since it is essential to have all amino acids in the 1eonfiguration to get full activity,5-7 the re- moval of the small amount of diastereoisomer produced at this stage resulted in some reduction in the yield of the desired all-1 octapeptide. We therefore chose the azide method which is known not to produce racemization.
Even here, Val-Tyr showed exceptional behavior, because it is especially easy (in comparison with the azides of other peptides) to convert its azide to the isocyanate by spontaneous Curtius rearranaement. Reaction of Circulation, Volume XXV, January 1962 0. 66 Al K, Co2 ?SM., 300 M7 I Table 1 Synthetic Angiotensins20 R HE* Asp-Arg-Val-Tyr-Val-His-Pro-Phc-His-Leu * OH this isocyanate does not produce the desired peptide but a disubstituted urea. Thus, the rearrangement was followed by infrared absorption (the isocyanate band at 4.45 develops from the -CON3 band at 4.65), and experimenital conditions were subsequently found in which isocyanate formation is negligible. The hexapeptide produced from the pure azide is stereochemically uniforim.
Stereochemical Purity of Valyl-5-Angiotensin II-Aspartyl-p-Amides23
It follows, from the characteristics of the synthesizing procedures employed, that the angiotensin amide produced might not be optically pure. Partial racemization is to be expected at certain poinits, especially in those .amino acid residues of intermediate peptides whose carboxyl groups are to be condensed with amino groups. In our case, these residues were Arg-2, Tyr-4 and, to a much lesser extent, His-6.
To find out whether or not the batches of anaiotenisin amide emaniating from our production were optically uniform, enzymic cleavage was first studied (fig. 2) . The resulting(r fragments were identified by paper chromatoaraphy and, in some cases, by isolation. The conditions -were such that uncleaved, Circulation, Volume XXV, January 1962 diastereoisomeric products in amounts down to 1 per cent could have been detected easily. Trypsin, chymotrypsin, and carboxypeptidase cleaved quantitatively the bonds Arg-2-Val-3, Tyr-4-Val-5, and Pro-7-Phe-8, respectively. These amino acids were thus shown to be in their natural i-configuration. Leucineaminopeptidase, which was completely free from prolidase, liberated all aminlo acids up to Val-5, showing that they all certainly were the i-isomers. In agreement with the specificity of leucineaminopeptidase, the His-6-Pro-7 bond was not split, and the reaction came ta an end there. Both pepsin and subtilisin split very slowly and acted on the bonds Val-3-Tyr-4 (pepsin) and Arg-2-Val-3 plus Tyr-4-
Val-5 (subtilisin).
This behavior of angiotensin amide demonstrated that it is composed of only 1 stereoisomer containing all amino acids in the i-form.
Some slight doubt about the configuration of His-6 still remained, however, because only 1 of its bonds was split (Val-5-His-6), and no enzyme was found which would cleave the other (His-6-Pro-7). We therefore treated anlgiotensiln amide with chymotrypsin and isolated the 2 These results indicate that if any stereoisomeric products had been produced during the synthesis, they would have been removed diiring the various purification steps. wlhich was proved to be true in 1 case.
The hexapeptide, H Val-Tyr-Val-His-Pro-Phe-OH, produced bv condeinsation of the dipeptide moiety, Val-Tyr, to the tetrapeptide portion, Val-His-Pro-Phe, with dicyclohexyl carbodiimide, showed a second, faster-moving spot on paper chromatography. This product was eliminated by countercurrent distributioni and other methods before proceeding with the synthesis of the octapeptide. We were able to show that this product was, indeed, a stereoisomeric hexapeptide containing d-tyrosine and all other amino acids in the i-form.
Hexapeptide mother liquors. in which the Figure 3 product was enriched, were treated witlh chymnotrypsin. The product in question remained unaltered and was separated by countercurrent distribution from the dipeptide, Val-Tyr, and the tetrapeptide, Val-His-Pro-Phe, which resulted from the all-l-hexapeptide. Its failure to react with chymotrypsin. as well as the results of treatment of the total hydrolysate with i-amino acid oxidase, revealed that d-tyrosine accounted for the whole amount of tyrosine present. Stability of Angiotensin Peptides Valyl-5-angiotensin II and, particularly, its aspartyl-/3-amides are not completely stable in aqueous solution which is the reason why ainpules containing angiotensin amide are usually lyophilized.
Circulation, Volume XXV, January 1962 Valvl-5-angiotensin II amide, when kept ini dilute aqueous solutionl at 50 C. for 6 moniths, retains almiiost full activity, but 90 per cenrt is coniverted into valyl-a-angiotenisin II by hydrolysis of the ainide grouping and about 10 per cent into the heptapeptide, HArg-Val-Tyr-Val-His-Pro-Phe OH, plus aspartic acid. Angiotenisin II is also converted, but more slowly, to the latter products.
The heptapeptide, which was also syilthesized,7' 23 elicits about half of the pressor aetivity of angiotensin in the nephrectomiized rat. This means that this aged solution contains more than 95 per cent of the pressor activity of the original.
The hydrolytic cleavage of the aspartinie residue is about as fast as that of glycine in Va1, .4iis (S%.his), Pro, PAh SCHIWYZER glycyl-1-angiotensin II.6,7 Stereochemical factors seem to facilitate the reaction in the case of glycine, and this is also true for aspartine, in the sense that special stereochemistry might promote the formation of a cyclic intermediate, as shown in the following formula: The suceinimide intermediate is presumably formed more easily than a corresponding suceinic anhydride intermediate from an aspartic acid residue. This would explain the more rapid formation of the heptapeptide from valyl-5-alngiotensin II-aspartyl-,-amides than from valyl-5-angiotensin II. Summary A short review is given of the development of synthetic angiotensin. Also discussed are enzymic experiments, showinga that production of the synthetic substance leads to valyl-5angiotensin-JI, in which all amino acids are completely in the i-configuration. Small amounts of diastereoisomers in intermediates, like 1-valyl-d-tyrosyl-l-valyl-l-histidyl-l-prolyl-1-phenylalaninae which was isolated and identified, are completely eliminated during the synthetic process. Valyl-5-angiotensin II-aspartyl-/3-amides are very slowly hydrolyzed in aqueous solution to valyl-5-angriotensin II and a small amount of the heptapeptide,
